我院于1975年～1980年采用化疗辅助手术综合治疗大肠癌50例(简称“辅化组”),并以本院外科同期住院未用化疗的50例大肠癌为对照(简称“对照组”)进行疗效对比分析。两组均为可手术的、非早期大肠癌,对比条件如表1。本组采用MFV或MFC(丝裂霉素+氟脲嘧啶+长春新硷或阿糖胞苷)联合化疗者43例。术后2～3周开始,前二周,每周给药2次,以后每周1次,共8～10次为一疗程。术 In our hospital from 1975 to 1980 chemotherapy-assisted surgery combined treatment of 50 cases of colorectal cancer (referred to as “assisted group”), and the hospital in the same period of hospital surgery without chemotherapy in 50 cases of colorectal cancer as a control (referred to as “control group” ) Conduct comparative analysis of efficacy. Both groups are operable, non-early colorectal cancer, and the comparison conditions are shown in Table 1. This group used MFV or MFC (mitomycin + fluorouracil + vinorelbine or cytarabine) combined chemotherapy in 43 cases. Two to three weeks after surgery, the first two weeks, two weekly doses, and then once a week, a total of 8 to 10 times for a course of treatment. Surgery